Cell and gene therapies
-
Gene therapies will deliver: Lilly SVP
- 12 Nov 2025
Eli Lilly SVP Gene Therapy and Gene Editing Manny Simons says despite recent failures, gene therapies will deliver in time and Australia could lead the way.
Read more -
MSAC bestows mixed blessing on CSL
- 12 Nov 2025
Resubmission gets a tick but with the recommended listing coming with no additional funding to standard of care, this deal is far from done.
Read more -
Ferring set for local gene therapy launch
- 22 Oct 2025
Receives local manufacturing approval for its novel gene therapy for bladder cancer, with TGA and MSAC applications likely to follow.
Read more -
MA, AusBiotech team up for CGT growth
- 01 Oct 2025
Joint launch of Advanced Therapies Advisory Group labelled ‘a timely and strategic move for Australia’s regenerative therapies sector’.
Read more -
Gilead, patients map road to recovery
- 22 Sep 2025
New patient-driven roadmap based on lived experience and clinical insights offers clarity for Australians facing aggressive lymphoma diagnoses.
Read more -
Patients win in rare cancer, cell therapy deals
- 16 Jul 2025
Rare Cancers Australia and Cell Therapies have both struck new agreements to benefit patients with rare or life-threatening disease.
Read more -
Gene therapy deaths spook markets
- 18 Jun 2025
Approved in eight markets including the US for Duchenne muscular dystrophy, the deaths following gene therapy is a blow for the emerging field.
Read more -
Excuse me, would you like a gene therapy?
- 06 Jun 2025
Aussies with inherited blood conditions are being asked their preferences, researchers hoping to find a path to reimbursement.
Read more